Zobrazeno 1 - 10
of 17
pro vyhledávání: '"S. L. Welkos"'
Autor:
A A Shea, R C Bernhards, C K Cote, C J Chase, J W Koehler, C P Klimko, J T Ladner, D A Rozak, M J Wolcott, D P Fetterer, S J Kern, G I Koroleva, S P Lovett, G F Palacios, R G Toothman, J A Bozue, P L Worsham, S L Welkos
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215200 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0171363.].
Externí odkaz:
https://doaj.org/article/c70b404be7194d8a896adb0f20b4615c
Autor:
A A Shea, R C Bernhards, C K Cote, C J Chase, J W Koehler, C P Klimko, J T Ladner, D A Rozak, M J Wolcott, D P Fetterer, S J Kern, G I Koroleva, S P Lovett, G F Palacios, R G Toothman, J A Bozue, P L Worsham, S L Welkos
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171363 (2017)
Burkholderia pseudomallei (Bp), the agent of melioidosis, causes disease ranging from acute and rapidly fatal to protracted and chronic. Bp is highly infectious by aerosol, can cause severe disease with nonspecific symptoms, and is naturally resistan
Externí odkaz:
https://doaj.org/article/ee4663dc08284bff8e60eef1ff205576
Publikováno v:
Current topics in microbiology and immunology. 271
The only impetus for the development of new anthrax vaccines is to protect humans against the intentional use of Bacillus anthracis as a bioterrorist or warfare agent. Live attenuated vaccines against anthrax in domesticated animals were among the ve
Publikováno v:
Current Topics in Microbiology and Immunology ISBN: 9783642077999
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a55be9151ad7a8a88eca0f03619ace7
https://doi.org/10.1007/978-3-662-05767-4_3
https://doi.org/10.1007/978-3-662-05767-4_3
Autor:
K J, Davis, P, Vogel, D L, Fritz, K E, Steele, M L, Pitt, S L, Welkos, A M, Friedlander, W R, Byrne
Publikováno v:
Archives of pathologylaboratory medicine. 121(8)
To identify alternatives to streptomycin for treating pneumonic plague, we evaluated beta-lactam antibiotics to treat experimental pneumonic plague in mice.Mice were exposed to a lethal inhaled dose of Yersinia pestis and treated with beta-lactam ant
Publikováno v:
Archives of pathologylaboratory medicine. 120(2)
The protein capsule of Yersinia pestis, known as Fraction 1 or F1, is a protective immunogen and is an assumed, but not proven, virulence factor. Our objectives were to determine if inhaled F1-negative and/or F1-positive strains of Y pestis were viru
Autor:
A M, Friedlander, S L, Welkos, P L, Worsham, G P, Andrews, D G, Heath, G W, Anderson, M L, Pitt, J, Estep, K, Davis
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 21
Yersinia pestis, the causative agent of plague, possesses multiple virulence determinants encoded on its three plasmids and on its chromosome. We evaluated the role of the protein capsule F1 in virulence an immunity against plague. Strains lacking F1
Publikováno v:
Contributions to microbiology and immunology. 13
Publikováno v:
Contributions to microbiology and immunology. 13